+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Darier Disease Drugs Market 2024-2028

  • PDF Icon

    Report

  • 134 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5637200
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The darier disease drugs market is forecasted to grow by USD 44.3 million during 2023-2028, accelerating at a CAGR of 4.49% during the forecast period. The report on the darier disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in demand for advanced dermatological diagnosis, launch of new darier disease drugs, and need for safe and stable drugs that require minimal monitoring.

The darier disease drugs market is segmented as below:

By Product

  • Topical retinoids
  • Oral retinoids
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing research on gene therapy as one of the prime reasons driving the darier disease drugs market growth during the next few years. Also, increase in prices of dermatological drugs and growing prevalence of lasers in treatment will lead to sizable demand in the market.

The report on the darier disease drugs market covers the following areas:

  • Darier disease drugs market sizing
  • Darier disease drugs market forecast
  • Darier disease drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading darier disease drugs market vendors that include AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Lomb Corp., BridgeBio Pharma Inc, Galderma SA, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Laminar Pharma, Mayne Pharma Group Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sawai Group Holdings Co. Ltd., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., and Validus Pharmaceuticals LLC. Also, the darier disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Darier Disease Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Darier Disease Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Topical retinoids - Market size and forecast 2023-2028
Chart on Topical retinoids - Market size and forecast 2023-2028 ($ million)
Data Table on Topical retinoids - Market size and forecast 2023-2028 ($ million)
Chart on Topical retinoids - Year-over-year growth 2023-2028 (%)
Data Table on Topical retinoids - Year-over-year growth 2023-2028 (%)
6.4 Oral retinoids - Market size and forecast 2023-2028
Chart on Oral retinoids - Market size and forecast 2023-2028 ($ million)
Data Table on Oral retinoids - Market size and forecast 2023-2028 ($ million)
Chart on Oral retinoids - Year-over-year growth 2023-2028 (%)
Data Table on Oral retinoids - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Bausch Lomb Corp.
Bausch Lomb Corp. - Overview
Bausch Lomb Corp. - Business segments
Bausch Lomb Corp. - Key offerings
Bausch Lomb Corp. - Segment focus
11.4 BridgeBio Pharma Inc
BridgeBio Pharma Inc - Overview
BridgeBio Pharma Inc - Product / Service
BridgeBio Pharma Inc - Key offerings
11.5 Galderma SA
Galderma SA - Overview
Galderma SA - Product / Service
Galderma SA - Key offerings
11.6 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.7 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key news
Glenmark Pharmaceuticals Ltd. - Key offerings
11.8 Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. - Overview
Mayne Pharma Group Ltd. - Business segments
Mayne Pharma Group Ltd. - Key news
Mayne Pharma Group Ltd. - Key offerings
Mayne Pharma Group Ltd. - Segment focus
11.9 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.10 Sigmapharm Laboratories LLC
Sigmapharm Laboratories LLC - Overview
Sigmapharm Laboratories LLC - Product / Service
Sigmapharm Laboratories LLC - Key offerings
11.11 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
11.12 Tolmar Pharmaceuticals Inc.
Tolmar Pharmaceuticals Inc. - Overview
Tolmar Pharmaceuticals Inc. - Product / Service
Tolmar Pharmaceuticals Inc. - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Darier Disease Drugs Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Topical retinoids - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Topical retinoids - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Topical retinoids - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Topical retinoids - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Oral retinoids - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Oral retinoids - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Oral retinoids - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Oral retinoids - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Product ($ million)
Exhibits 47: Data Table on Market opportunity by Product ($ million)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: Bausch Lomb Corp. - Overview
Exhibits 98: Bausch Lomb Corp. - Business segments
Exhibits 99: Bausch Lomb Corp. - Key offerings
Exhibits 100: Bausch Lomb Corp. - Segment focus
Exhibits 101: BridgeBio Pharma Inc - Overview
Exhibits 102: BridgeBio Pharma Inc - Product / Service
Exhibits 103: BridgeBio Pharma Inc - Key offerings
Exhibits 104: Galderma SA - Overview
Exhibits 105: Galderma SA - Product / Service
Exhibits 106: Galderma SA - Key offerings
Exhibits 107: GlaxoSmithKline Plc - Overview
Exhibits 108: GlaxoSmithKline Plc - Business segments
Exhibits 109: GlaxoSmithKline Plc - Key news
Exhibits 110: GlaxoSmithKline Plc - Key offerings
Exhibits 111: GlaxoSmithKline Plc - Segment focus
Exhibits 112: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 113: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 114: Glenmark Pharmaceuticals Ltd. - Key news
Exhibits 115: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 116: Mayne Pharma Group Ltd. - Overview
Exhibits 117: Mayne Pharma Group Ltd. - Business segments
Exhibits 118: Mayne Pharma Group Ltd. - Key news
Exhibits 119: Mayne Pharma Group Ltd. - Key offerings
Exhibits 120: Mayne Pharma Group Ltd. - Segment focus
Exhibits 121: Novartis AG - Overview
Exhibits 122: Novartis AG - Business segments
Exhibits 123: Novartis AG - Key news
Exhibits 124: Novartis AG - Key offerings
Exhibits 125: Novartis AG - Segment focus
Exhibits 126: Sigmapharm Laboratories LLC - Overview
Exhibits 127: Sigmapharm Laboratories LLC - Product / Service
Exhibits 128: Sigmapharm Laboratories LLC - Key offerings
Exhibits 129: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 130: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 131: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 132: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 133: Tolmar Pharmaceuticals Inc. - Overview
Exhibits 134: Tolmar Pharmaceuticals Inc. - Product / Service
Exhibits 135: Tolmar Pharmaceuticals Inc. - Key offerings
Exhibits 136: Inclusions checklist
Exhibits 137: Exclusions checklist
Exhibits 138: Currency conversion rates for US$
Exhibits 139: Research methodology
Exhibits 140: Information sources
Exhibits 141: Data validation
Exhibits 142: Validation techniques employed for market sizing
Exhibits 143: Data synthesis
Exhibits 144: 360 degree market analysis
Exhibits 145: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global darier disease drugs market: AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Lomb Corp., BridgeBio Pharma Inc, Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Laminar Pharma, Mayne Pharma Group Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sawai Group Holdings Co. Ltd., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., and Validus Pharmaceuticals LLC.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing research on gene therapy."

According to the report, one of the major drivers for this market is the increase in demand for advanced dermatological diagnosis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Bausch Lomb Corp.
  • BridgeBio Pharma Inc
  • Galderma SA
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson and Johnson Services Inc.
  • Laminar Pharma
  • Mayne Pharma Group Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sawai Group Holdings Co. Ltd.
  • Sigmapharm Laboratories LLC
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals Inc.
  • Validus Pharmaceuticals LLC

Related Topics

Related Reports

Darier Disease Drugs Market by Treatment Type, Drugs, Distribution Channel, End- User - Global Forecast 2025-2030 - Product Image

Darier Disease Drugs Market by Treatment Type, Drugs, Distribution Channel, End- User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Rosacea Treatment Market 2024-2028 - Product Image

Rosacea Treatment Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Darier Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Darier Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 176 Pages
  • Global
From
Dermatological Drugs Market 2024-2028 - Product Image

Dermatological Drugs Market 2024-2028

  • Report
  • 139 Pages
  • Global
From
Global Tinea Pedis Treatment Market Report 2024 - Product Image

Global Tinea Pedis Treatment Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.